These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23441636)

  • 1. Arginine vasopressin V1a receptor-deficient mice have reduced brain edema and secondary brain damage following traumatic brain injury.
    Rauen K; Trabold R; Brem C; Terpolilli NA; Plesnila N
    J Neurotrauma; 2013 Aug; 30(16):1442-8. PubMed ID: 23441636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.
    Trabold R; Krieg S; Schöller K; Plesnila N
    J Neurotrauma; 2008 Dec; 25(12):1459-65. PubMed ID: 19118456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
    Krieg SM; Sonanini S; Plesnila N; Trabold R
    J Neurotrauma; 2015 Feb; 32(4):221-7. PubMed ID: 25111427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury.
    Krieg SM; Trabold R; Plesnila N
    J Neurotrauma; 2017 Apr; 34(7):1329-1336. PubMed ID: 27762660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin V
    Rauen K; Pop V; Trabold R; Badaut J; Plesnila N
    J Neurotrauma; 2020 Feb; 37(4):665-674. PubMed ID: 31547764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
    Kleindienst A; Dunbar JG; Glisson R; Marmarou A
    Acta Neurochir (Wien); 2013 Jan; 155(1):151-64. PubMed ID: 23188468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of vasopressin v1a receptors after traumatic brain injury.
    Szmydynger-Chodobska J; Chung I; Koźniewska E; Tran B; Harrington FJ; Duncan JA; Chodobski A
    J Neurotrauma; 2004 Aug; 21(8):1090-102. PubMed ID: 15319008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats.
    Filippidis AS; Liang X; Wang W; Parveen S; Baumgarten CM; Marmarou CR
    J Neurotrauma; 2014 Jul; 31(14):1258-67. PubMed ID: 24635833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
    Marmarou CR; Liang X; Abidi NH; Parveen S; Taya K; Henderson SC; Young HF; Filippidis AS; Baumgarten CM
    Brain Res; 2014 Sep; 1581():89-102. PubMed ID: 24933327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traumatic brain injury results in a concomitant increase in neocortical expression of vasopressin and its V1a receptor.
    Pascale CL; Szmydynger-Chodobska J; Sarri JE; Chodobski A
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():161-7. PubMed ID: 17244947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glibenclamide reduces secondary brain damage after experimental traumatic brain injury.
    Zweckberger K; Hackenberg K; Jung CS; Hertle DN; Kiening KL; Unterberg AW; Sakowitz OW
    Neuroscience; 2014 Jul; 272():199-206. PubMed ID: 24792709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice.
    Peng F; Qu ZW; Qiu CY; Liao M; Hu WP
    Neurosci Lett; 2015 Apr; 593():61-5. PubMed ID: 25782631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice.
    Zweckberger K; Erös C; Zimmermann R; Kim SW; Engel D; Plesnila N
    J Neurotrauma; 2006 Jul; 23(7):1083-93. PubMed ID: 16866621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury.
    Luh C; Kuhlmann CR; Ackermann B; Timaru-Kast R; Luhmann HJ; Behl C; Werner C; Engelhard K; Thal SC
    J Neurochem; 2010 Feb; 112(4):1015-25. PubMed ID: 19943851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.
    Taya K; Gulsen S; Okuno K; Prieto R; Marmarou CR; Marmarou A
    Acta Neurochir Suppl; 2008; 102():425-9. PubMed ID: 19388360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proneurotrophin Binding to P75 Neurotrophin Receptor (P75ntr) Is Essential for Brain Lesion Formation and Functional Impairment after Experimental Traumatic Brain Injury.
    Sebastiani A; Gölz C; Werner C; Schäfer MK; Engelhard K; Thal SC
    J Neurotrauma; 2015 Oct; 32(20):1599-607. PubMed ID: 25879397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and histological effects of traumatic brain injury in eNOS-deficient mice.
    Lundblad C; Grände PO; Bentzer P
    J Neurotrauma; 2009 Nov; 26(11):1953-62. PubMed ID: 19929218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice.
    Zeynalov E; Jones SM; Seo JW; Snell LD; Elliott JP
    PLoS One; 2015; 10(8):e0136121. PubMed ID: 26275173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mildly Reduced Brain Swelling and Improved Neurological Outcome in Aquaporin-4 Knockout Mice following Controlled Cortical Impact Brain Injury.
    Yao X; Uchida K; Papadopoulos MC; Zador Z; Manley GT; Verkman AS
    J Neurotrauma; 2015 Oct; 32(19):1458-64. PubMed ID: 25790314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.